Work

Phase II Trials of High-Dose Interleukin-2 and Lymphokine-Activated Killer Cells in Advanced Breast Carcinoma and Carcinoma of the Lung, Ovary, and Pancreas and Other Tumors

Year: 1994

Type: article

Study design: Clinical Trial

Source: Journal of Immunotherapy

DOI: 10.1097/00002371-199410000-00006

Authors: Joseph A. Sparano, Richard I. Fisher, Geoffrey R. Weiss, Kim Margolin, Frederick R. Aronson, Michael J. Hawkins, Michael B. Atkins, Janice P. Dutcher, Ellen R. Gaynor, David H. Boldt, James H. Doroshow, Mary Lou Ernest, Mario Sznol, James W. Mier

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Yeshiva University, Montefiore Einstein Comprehensive Cancer Center, Loyola University Medical Center, Loyola University Chicago, The University of Texas at San Antonio Health Science Center, City Of Hope National Medical Center, City of Hope, University of California, San Francisco, National Institutes of Health, Tufts University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1105070095, G1505869703, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, G2197280113, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

OpenAlex ID: W2042748313

FWCI: 0.287

Cites:

Cited by: 36

Related to: 10